Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

COPP regimen

View Patient Information
A regimen that is a derivative of the original MOPP regimen consisting of cyclophosphamide, vincristine, procarbazine and prednisone used as an initial treatment for Hodgkin lymphoma. Also used for the treatment of non-Hodgkin lymphoma.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:cyclophosphamide-Oncovin-procarbazine-prednisone regimen
cyclophosphamide/prednisone/procarbazine/vincristine
Cytoxan-Oncovin-procarbazine-prednisone regimen
Abbreviation:CTX/PCB/PRED/VCR
Acronym:COPP
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search